Nusinersen
Last Updated: 02/24/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1009 publications
Impaired renal function in patients with spinal muscular atrophy: A longitudinal cohort study.
Journal: Journal of neuromuscular diseases
Published: January 16, 2026
Pharmacoeconomic evaluation of spinal muscular atrophy therapy in patients with four SMN2 copies diagnosed through newborn screening
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: January 12, 2026
CRISPR-Cas editing technologies for viral-mediated gene therapies of human diseases: Mechanisms, progress, and challenges.
Journal: Molecular therapy. Nucleic acids
Published: January 07, 2026
Real-Time Ultrasound-Guided Intrathecal Delivery of Nusinersen in Adult Patients With Spinal Muscular Atrophy and Complex Spinal Anatomy.
Journal: Pain physician
Published: December 03, 2025
Pharmacokinetics of therapies approved for spinal muscular atrophy: A narrative review of current evidence.
Journal: The Journal of international medical research
Published: November 27, 2025
Hip Displacement in Spinal Muscular Atrophy in the Early Disease-Modifying Therapy Era: Association With Hip Pain and Timing of Therapy Initiation.
Journal: Journal of pediatric orthopedics
Published: November 11, 2025
Onasemnogene abeparvovec gene therapy for treatment of patients with spinal muscular atrophy: Updated real-world practical considerations.
Journal: Journal of neuromuscular diseases
Published: November 10, 2025
Matched-pair analysis of motor outcomes in adults with spinal muscular atrophy on nusinersen vs. risdiplam.
Journal: Journal of neurology
Published: November 03, 2025
Real-world evidence on nusinersen treatment of persons with SMA: a focused review.
Journal: Journal of neuromuscular diseases
Published: October 25, 2025
A therapeutic antisense oligonucleotide encompassing 2'-O-methoxyethyl modification triggers unique perturbation of the transcriptome.
Journal: NAR molecular medicine
Published: October 14, 2025
Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1.
Journal: JAMA network open
Published: October 08, 2025
Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions.
Journal: Frontiers in pharmacology
Published: October 07, 2025
Last Updated: 02/24/2026